Industry news
-
04 October 2013
Russia sinks $1.5 billion into U.S. tech firms
David Miller, Russia Beyond the Headlines
Russia aims to boost technology-led economic growth at home by pouring money into technology start-ups and venture funds — including $1.5 billion in the U.S.
-
04 October 2013
ROSNANO will allocate additional financing to “Russian Membranes”
Venture News
The board of directors at the meeting in absentia has taken decision about changing the main parameters of ROSNANO participation in the investment project “Russian Membranes: modern production establishment of nano-structural membranes and separation modules on its basis”.
-
04 October 2013
Dmitry Medvedev: Development of “Skolkovo” will be continued
Venture News
In the article, named as “Time of simple solutions has gove”, the Head of Government says about reset of import taxes for scientific equipment and materials, and calls large Russian companies to invest money in science more actively, and Government – find opportunities to stimulate such investments.
-
01 October 2013
Investors will allocate $1,35M for establishment of the largest medical resource
Venture News
Venture funds Runa Ñapital, Prostor Capital and Internet-group Fastlane Ventures have combined a part of their securities for establishment of the medical online Internet-company, and consolidation of the Internet healthcare segment.
-
01 October 2013
The portfolio Company of ROSNANO “BIND Therapeutics” has conducted IPO at NAS
Venture News
BIND Therapeutics, Inc., the portfolio company of ROSNANO, has finished the IPO of 4.700.000 common shares. Cost of IPO comprised $15.00 per one share. In the result of BIND Therapeutics’s IPO, there has been attracted $70.5M (before the discount and underwriters’ commission deduction).
-
26 September 2013
Hydrogel inlay improves uncorrected near visual acuity in presbyopic emmetropic eyes
Matt Hasson, Ocular Surgery News U.S. Edition
The inlay creates multifocality at the corneal plane, with near vision on the visual axis and a transition to intermediate, distance vision out to the periphery.
-
26 September 2013
Oksana Teplinskaya, The Voice of Russia
With Russia pegged as one of the world's fastest-growing markets, drug makers have been angling to build up their businesses here. For free access to the market, the Russian government now requires foreign companies to team up with local players – and to share technology with them.
-
26 September 2013
Pharma packaging growing market with openings for good ideas
Eric Palmer, FiercePharmaManufacturing
Market expected to grow at 5.6% annually through 2018.
-
22 September 2013
Viktor Voronkov, Skolkovo
On September 17 in Boston and September 19-20 in Santa-Clara, Silicon Valley, 65 Russian start-ups will present their projects to American investors at a conference entitled Russian Innovation Week (RIW).
-
18 September 2013
Advance Pharmaceutical to invest $25 million in building plant in Russia
The Pharma Letter
USA-based privately-held drugmaker Advance Pharmaceutical Inc is considering establishing a facility for the production of its drugs in Russia’s Belgorod region (Central Russia), according to the company. Advance Pharmaceutical engages in the design, research and development, manufacture, marketing and distribution of prescription and over the counter pharmaceutical products.
All Portfolio
MEDIA CENTER
-
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.